Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Douglas E. Joseph, DO, RVT, is Director of the Vascular Medicine Outpatient Department in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Sydell and Arnold Miller Family Heart & Vascular Institute at Cleveland Clinic. He is also medical director for the Vascular Medicine Vein Health Clinic and co-medical director of the multi-disciplinary lymphedema clinic. He is board-certified in vascular medicine and Internal Medicine and is a registered vascular technologist (RVT) and Registered Physician in Vascular Interpretation (RPVI).
Currently his clinical and research interests involve chronic venous insufficiency and varicose veins. He performs endovenous ablation, microphlebectomies and sclerotherapy on the main campus as well as at multiple regional facilities.
Dr. Joseph earned a Doctorate of Osteopathy at Des Moines University College of Osteopathic Medicine. He completed an internship and internal medicine residency at St. Vincent Mercy Medical Center in Toledo, Ohio followed by a fellowship in vascular medicine at Cleveland Clinic. He was appointed to the medical staff in 2004.
Dr. Joseph has published a number of papers in medical journals on peripheral arterial disease, heparin-induced thrombocytopenia and deep vein thrombosis. He also has authored two textbook chapters and a monograph on heparin-induced thrombocytopenia.
Dr. Joseph also is a frequent presenter at medical symposia hosted at Cleveland Clinic and elsewhere, speaking on prevention of venous thromboembolism following surgery, peripheral artery disease, lower extremity wounds and management of primary venous disease.
His professional memberships include the Society of Diagnostic Medical Sonography, American Venous Forum, Society for Vascular Medicine, American Medical Association and American College of Physicians, American Society of Internal Medicine and he is a Fellow of the American Osteopathic Association.
Veins, vein ablation, varicose veins, varicose vein ablation, sclerotherapy, spider veins, venous disorders, lymphedema, general vascular medicine, vascular diseases Hypercoagulable states, lymphedema, chronic venous insufficiency, varicose veins, general vascular medicine, vascular diseases, non-invasive testing for vascular disease, sclerotherapy
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland
Clinic's procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 8/31/2014 the review process regarding Dr. Joseph's disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.